Drug-Drug Interactions via Mechanism-Based Cytochrome P450 Inactivation: Points to Consider for Risk Assessment from In Vitro Data and Clinical Pharmacologic Evaluation

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|8|5|449-462

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.8, Iss.5, 2007-06, pp. : 449-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanism-Based Inactivation of Cytochrome P450 Enzymes: Chemical Mechanisms, Structure-Activity Relationships and Relationship to Clinical Drug-Drug Interactions and Idiosyncratic Adverse Drug Reactions

By  

Current Drug Metabolism, Vol. 8, Iss. 5, 2007-06 ,pp. : 407-447

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of Drug-Drug Interactions Arising From Mechanism-Based Inactivation: Key Input Parameters and Impact on Risk Assessment

By  

Current Drug Metabolism, Vol. 12, Iss. 9, 2011-11 ,pp. : 871-890

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of Drug Interactions with P-Glycoprotein in Drug Discovery: In Vitro Assessment of the Potential for Drug-Drug Interactions with P-Glycoprotein

By  

Current Drug Metabolism, Vol. 3, Iss. 3, 2002-06 ,pp. : 257-273

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging In Vitro Tools to Evaluate Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions

By  

Current Drug Discovery Technologies, Vol. 7, Iss. 3, 2010-09 ,pp. : 199-222

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 Part 3: Impact of Drug‐Drug Interactions

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 1, 2009-03 ,pp. : 55-58

John Wiley & Sons Inc

Access to resources Recommend Favorite